The elucidation of the SOAT1 protein crystal structure provides an opportunity to develop a more potent and safer SOAT1 inhibitor with specific binding and high absorptivity, potentially paving the way for the next generation of SOAT1-targeted therapy in cancer (70). The gene discussed is SOAT1; the disease is cancer.